Glycostem to participate in an virtual event hosted by the Netherlands Enterprise Agency (Rijksdienst voor Ondernemend Nederland, RVO): Scale-up mission Biotech - Boston and New York, during 21st May to 24th June, 2021.
Glycostem will present on the virtual Advanced Therapies Congress & Expo 2021 during 19th to 21st May, 2021. Advanced Therapies Congress & Expo is the world’s largest commercially focused ATMP event and this is the virtual event. An in-person event will be held on 5th and 6th October 2021 in London.
Glycostem to present virtually on the 3rdAllogeneic Cell Therapies Summit on 19th May 2021, to share our experiences on comparability testing for US required raw material sourcing vs. European sourcing.
Glycostem will present on the virtual Berenberg Conference USA 2021 on 18th May, 2021, to share the latest updates of our company and products, and host one-on-one meetings with investors.
Glycostem to present at the 18th CIMT Annual Meeting virtually with etalk presentation: Ex vivo expanded NK cells show potent anti-tumour activity against melanoma.
Glycostem to present at virtual event Stability V: Challenges of in-use stability demonstration hosted by Joint Pharmaceutical Analysis Group, to talk about in use stability considerations for large molecules.